The prognosis of hydrops fetalis varies widely depending on the cause and the effectiveness of treatment. Immune hydrops has a better prognosis when managed appropriately with interventions like intrauterine transfusions. However, non-immune hydrops, especially due to genetic or structural anomalies, often carries a poorer prognosis. Early detection and targeted management are crucial in improving outcomes.
